Bone marrow-derived CD34- fraction: A rich source of mesenchymal stromal cells for clinical application

Bone marrow-derived CD34^- fraction: A rich source of mesenchymal stromal cells for clinical application

Cytotherapy. 2016 Dec;18(12):1560-1563. doi: 10.1016/j.jcyt.2016.08.011. Epub 2016 Oct 11.

¹ San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology, San Raffaele Scientific Institute, Milan, Italy.
² Immunohematology and Transfusion Medicine Unit, San Raffaele Scientific Institute, Milan, Italy.
³ Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
⁴ San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
⁵ San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: bernardo.mariaester@hsr.it.

No abstract available

Keywords: CD34(−) negative fraction; engraftment; hematopoietic stem cell transplantation; mesenchymal stromal cells.